<VariationArchive VariationID="1033181" VariationName="NM_170606.3(KMT2C):c.8543del (p.Asn2848fs)" VariationType="Deletion" Accession="VCV001033181" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2021-03-22" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1020346" VariationID="1033181">
      <GeneList>
        <Gene Symbol="KMT2C" FullName="lysine methyltransferase 2C" GeneID="58508" HGNC_ID="HGNC:13726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="152134925" stop="152436003" display_start="152134925" display_stop="152436003" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="151832009" stop="152133089" display_start="151832009" display_stop="152133089" Strand="-" />
          </Location>
          <OMIM>606833</OMIM>
          <Haploinsufficiency last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2C">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2C">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_170606.3(KMT2C):c.8543del (p.Asn2848fs)</Name>
      <CanonicalSPDI>NC_000007.14:152176909:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="152176910" stop="152176910" display_start="152176910" display_stop="152176910" variantLength="1" positionVCF="152176909" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="151873995" stop="151873995" display_start="151873995" display_stop="151873995" variantLength="1" positionVCF="151873994" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>N2848fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.151873996del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.151873996del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.152176911del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.152176911del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033948.1" sequenceAccession="NG_033948" sequenceVersion="1" change="g.264096del">
            <Expression>NG_033948.1:g.264096del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170606.3" sequenceAccession="NM_170606" sequenceVersion="3" change="c.8543del" MANESelect="true">
            <Expression>NM_170606.3:c.8543del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_733751.2" sequenceAccession="NP_733751" sequenceVersion="2" change="p.Asn2848fs">
            <Expression>NP_733751.2:p.Asn2848fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170606.3" sequenceAccession="NM_170606" sequenceVersion="3" change="c.8543delA" MANESelect="true">
            <Expression>NM_170606.3:c.8543delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2093235396" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_170606.3(KMT2C):c.8543del (p.Asn2848fs) AND Kleefstra syndrome 1" Accession="RCV001335515" Version="1">
        <ClassifiedConditionList TraitSetID="948">
          <ClassifiedCondition DB="MedGen" ID="C0795833">Kleefstra syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-04-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_170606.3(KMT2C):c.8543del (p.Asn2848fs) AND Kleefstra syndrome 2" Accession="RCV004557543" Version="1">
        <ClassifiedConditionList TraitSetID="39647">
          <ClassifiedCondition DB="MedGen" ID="C4540395">Kleefstra syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-11" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2021-03-22" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome 1</ElementValue>
                <XRef ID="MONDO:0027407" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsyÂ / febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty.</Attribute>
                <XRef ID="NBK47079" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20945554</ID>
                <ID Source="BookShelf">NBK47079</ID>
              </Citation>
              <XRef ID="261494" DB="Orphanet" />
              <XRef ID="C0795833" DB="MedGen" />
              <XRef ID="MONDO:0027407" DB="MONDO" />
              <XRef Type="MIM" ID="610253" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="39647" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38345" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome 2</ElementValue>
                <XRef ID="MONDO:0054701" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KLEFS2</ElementValue>
                <XRef Type="MIM" ID="617768" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18382" />
                <XRef ID="18382" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4540395" DB="MedGen" />
              <XRef ID="MONDO:0054701" DB="MONDO" />
              <XRef Type="MIM" ID="617768" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3003895" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_170606.2:c.8543delA|OMIM:610253" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001528680" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2C" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_170606.2:c.8543delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610253" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9799058" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="NM_170606.3:c.8543del|OMIM:617768" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005049331" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_170606.3:c.8543del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617768" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES_20231129_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3003895" TraitType="Disease" MappingType="XRef" MappingValue="610253" MappingRef="OMIM">
        <MedGen CUI="C0795833" Name="Kleefstra syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9799058" TraitType="Disease" MappingType="XRef" MappingValue="617768" MappingRef="OMIM">
        <MedGen CUI="C4540395" Name="Kleefstra syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

